Filing Details

Accession Number:
0001447028-21-000068
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-03 16:02:53
Reporting Period:
2021-12-01
Accepted Time:
2021-12-03 16:02:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1447028 Arbutus Biopharma Corp ABUS Pharmaceutical Preparations (2834) 980597776
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1635324 J. Michael Sofia C/O Arbutus Biopharma Corporation
701 Veterans Circle
Warminster PA 18974
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2021-12-01 200,000 $5.09 1,303,403 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 167,162 Indirect By Trust
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2021.
  2. These shares are owned by the Irrevocable Deeds of Trust of Michael J. Sofia dated July 6, 2020 (the "Trusts"). The reporting person's wife and adult children are both the Trustees and the beneficiaries of the Trusts. The reporting person disclaims beneficial ownership of the shares owned by the Trusts and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.